CB2受容体を制御するジアゼパン化合物 - Boehringer Ingelheim International GmbH

Title:

CB2受容体を制御するジアゼパン化合物

Document Type and Number:

Japanese Patent JP2011500820

Kind Code:

A

Abstract:

Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.

More Like This:

JPH0249775	HETEROCYCLIC COMPOUND HAVING 6-MEMBERED OR 7-MEMBERED RING AND PRODUCTION THEREOF
JP5745406	Substituted aminoindane and its analogs, and their pharmaceutical use
JP2009538270	Cell replication disrupting agents and their use in blocking pathological conditions

Inventors:

Cirillo Pierre Francesco
Hicky Eugene Richard
Leeter Doris
Wu Li Feng
Sindel Lenny
Amousze Patricia
Herman Monica
Walker edward

Application Number:

JP2010531160A

Publication Date:

January 06, 2011

Filing Date:

October 21, 2008

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Boehringer Ingelheim International GmbH

International Classes:

C07D243/08; A61K31/551; A61P1/00; A61P1/02; A61P1/04; A61P1/16; A61P1/18; A61P5/00; A61P5/14; A61P5/48; A61P7/00; A61P7/04; A61P7/06; A61P7/10; A61P9/00; A61P9/10; A61P11/00; A61P11/02; A61P11/04; A61P11/06; A61P11/08; A61P11/16; A61P13/02; A61P13/08; A61P13/10; A61P13/12; A61P15/00; A61P17/00; A61P17/02; A61P17/04; A61P17/06; A61P19/00; A61P19/02; A61P19/06; A61P19/08; A61P21/00; A61P21/04; A61P25/00; A61P25/06; A61P25/14; A61P25/16; A61P25/28; A61P27/02; A61P27/16; A61P29/00; A61P31/04; A61P31/08; A61P31/12; A61P31/16; A61P31/18; A61P31/22; A61P35/00; A61P35/02; A61P35/04; A61P37/00; A61P37/08; A61P43/00; C07D401/04; C07D401/14; C07D403/04; C07D403/14; C07D405/14; C07D413/04; C07D413/14; C07D417/04; C07D417/14; C07D473/32; C07D491/048; C07D495/04; C07D498/04

Domestic Patent References:

JP2006504663A

2006-02-09

Foreign References:

WO2004110376A2	2004-12-23
WO2007056046A1	2007-05-18
WO2007070506A2	2007-06-21
WO2006106423A2	2006-10-12
WO2007126935A2	2007-11-08

Other References:

JPN7012003850; ＦＥＢＳ　ＬＥＴＴＥＲＳ４３６, 1998, ｐｐ．４４９-５４
JPN7012003851; ＰＨＡＲＭＡＣＯＬＯＧＹ　＆　ＴＨＥＲＡＰＥＵＴＩＣＳ１０６, 2005, ｐｐ．１３３-４５
JPN7012003848; ＥＵＲＯＰＥＡＮ　ＪＯＵＲＮＡＬ　ＯＦ　ＭＥＤＩＣＩＮＡＬ　ＣＨＥＭＩＳＴＲＹ４３, 2008, ｐｐ．１５７０-７４
JPN7012003849; ＪＯＵＲＮＡＬ　ＯＦ　ＭＥＤＩＣＩＮＡＬ　ＣＨＥＭＩＳＴＲＹ４８（６）, 2005, ｐｐ．１８５７-７２

Attorney, Agent or Firm:

Koichi Tsujii
Sadao Kumakura
Nobuo Ogawa
Atsushi Hakoda
Kenji Asai
Kazuo Yamazaki
Akizawa

Previous Patent: アリルインデノピリミジン及びアデノシンＡ２ａ受容体拮抗物質としての�...

Next Patent: 減量を誘発及び援助するためのプロバイオティック組成物及び方法